|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.308 EUR | -0.28% |
|
+0.35% | +15.74% |
| 13/01 | Evotec says Michael Kaufman holds 5.03% of total voting rights and instruments in Evotec | RE |
| 08/01 | Evotec Receives Gates Foundation Grant to Deploy AI in Optimizing Monoclonal Antibodies | MT |
Group Evotec SE: Relations chart
Private companies belonging to the same group as EVOTEC SE
| Company | Manager |
|---|---|
Evotec (France) SAS
 Evotec (France) SAS Engages in research and development of physical and natural sciences | Pierre Cooremans |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | - |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Matthias Evers |
Aptuit (Verona) Srl
 Aptuit (Verona) Srl Develops and manufactures drugs and medicines | Ciriaco Maraschiello |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition